(www.neomundo.com.ar)-_Una_prueba_de_sangre_podrÃa_servir_de_ayuda_para_diagnosticar_la_depresión,_enfermedad_que_de_acuerdo_con_datos_de_la_Organización_Mundial_de_la_Salud_(OMS) is currently one of the leading causes of disability worldwide.
)
Researchers from the Massachusetts General Hospital (United States) that put to test the new test explained that traditionally the depression is diagnosed from symptoms of the patient but ″la effectiveness of the process presents large variations, especially depending on the experience and resources of the doctor to cargo″.
John Bilello, President of the Ridge Diagnostics Laboratory, which designed the test, said that ″puede be difficult to convince of the need for patients to follow a treatment based on the questionnaire that is today used to evaluate symptoms of depression. We hope that the biological bases of this test to achieve that patients see their depression as a treatable disease rather than as a source of trauma and stigma. ″
the new test measures nine compounds or biomarkers that circulate in blood and are associated with the body’s response to stress. With the concentration of each data specialists applied a specific formula indicating the possibility that the patient is suffering from a depression. ″La biology of depression suggests that a complex series of interactions exist between the brain and the biomarkers in the circulación″, Bilello said.
Psychiatrist George Papakostas put this system to the test with two group of volunteers which included, in both cases, depressed people and other healthy. To examine the efficacy of the new blood test the expert noticed that efficiently serves to differentiate people with depression which do not have this evil.
Papakostas but explains that it is necessary to conduct studies with a greater number of volunteers to verify the effectiveness of the test.
More information about health and science by visiting the www.neomundo.com.ar site – simply click with your mouse above on the logo of NEOMUNDO
